腎臓内科
腎臓内科業績
- "Correction to: Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease. " Ishigaki S, Ohashi N, Isobe S, Tsuji N, Iwakura T, Ono M, Sakao Y, Tsuji T, Kato A, Miyajima H, Yasuda H. Clin Exp Nephrol. 23(2):289-290, 2019.
- "Night-time activation of the intrarenal renin-angiotensin system due to nocturnal hypertension is associated with renal arteriosclerosis in normotensive IgA nephropathy patients. " Ohashi N, Isobe S, Matsuyama T, Ishigaki S, Tsuji N, Fujikura T, Tsuji T,Kato A, Yasuda H. Hypertens Res. 41(5):334-341, 2018.
- "The impact of serum uric acid reduction on renal function and blood pressure in chronic kidney disease patients with hyperuricemia. " Tsuji T, Ohishi K, Takeda A, Goto D, Sato T, Ohashi N, Fujigaki Y, Kato A, Yasuda H. Clin Exp Nephrol. 22(6):1300-1308, 2018.
英文業績
1. Fujikura T, Yasuda H, Iwakura T, Tsuji T, Anders HJ. MDM2 inhibitorameliorates cisplatin-induced nephropathy via NFκΒ signal inhibition. Pharmacol Res Perspect. 2018 Dec 13;7(1):e00450
2. Matsuyama T, Ohashi N, Ishigaki S, Isobe S, Tsuji N, Fujikura T, Tsuji T, Kato A, Miyajima H, Yasuda H. The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function. Intern Med.;57(22):3241-3247, 2018
3. Ishigaki S, Ohashi N, Isobe S, Tsuji N, Iwakura T, Ono M, Sakao Y, Tsuji T, Kato A, Miyajima H, Yasuda H. Correction to: Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease. Clin Exp Nephrol. 23(2):289-290, 2019.
4. Ohashi N, Isobe S, Matsuyama T, Ishigaki S, Suzuki T, Tsuji T, Otsuka A, Kato A, Miyake H, Yasuda H. The Intrarenal Renin-angiotensin System Is Activated Immediately after Kidney Donation in Kidney Transplant Donors. Intern Med. 58(5):643-648, 2019.
5. Ohashi N, Isobe S, Matsuyama T, Ishigaki S, Tsuji N, Fujikura T, Tsuji T,Kato A, Yasuda H. Night-time activation of the intrarenal renin-angiotensin system due to nocturnal hypertension is associated with renal arteriosclerosis in normotensive IgA nephropathy patients. Hypertens Res. 41(5):334-341, 2018.
6. Sakao Y, Ohashi N, Sugimoto M, Ichikawa H, Sahara S, Tsuji T, Kato A, Fujigaki Y, Sugimoto K, Furuta T, Yasuda H. Gender differences in plasma ghrelin levels in hemodialysis patients. Ther Apher Dial 23:65-72, 2018.
7. Sahara S, Sugimoto M, Ichikawa H, Kagami T, Sakao Y, Ohashi N, Horio Y, Sugimoto K, Kato A, Furuta T, Yasuda H: Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial. Digestion 97: 163-169, 2018.
8. Ichikawa H, Sugimoto M, Sakao Y, Sahara S, Ohashi N, Sano K, Tadokoro S, Azekura H, Shimomura A, Yamashita F, Sugiyama D, Fukuta K, Furuta T, Kato A, Sugimoto K, Yasuda H. Eradication therapy for Helicobacter pylori infection improves nutrition status in Japanese hemodialysis patients: a pilot study. J Clin Biochem Nutr. 64(1):91-95, 2019.
9. Sakao Y,Ohashi N,Sugimoto M,Ichikawa H,Sahara S,Tsuji T,Kato A,Fujigaki Y,Sugimoto K,Furuta T,Yasuda H.Gender Differences in Plasma Ghrelin Levels in Hemodialysis Patients.Ther Apher Dial. 23(1):65-72, 2019.
10. Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T,Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K,Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, ShirasakiA, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K,Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R,Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y. Regionalvariations in immunosuppressive therapy in patients with primary nephroticsyndrome: the Japan nephrotic syndrome cohort study. Clin Exp Nephrol. 2018Dec;22(6):1266-1280.
11. Sugimoto M, Yasuda H, Andoh A. Nutrition status and Helicobacter pylori nfection in patients receiving hemodialysis. World J Gastroenterol. 24(15):1591-1600, 2018.
12. Niwa H, Fukasawa H, Ishibuchi K, Kaneko M, Yasuda H, Furuya R. Effects ofLowering Dialysate Calcium Concentration on Bone Metabolic Markers in Hemodialysis Patients With Suppressed Serum Parathyroid Hormone: A Preliminary Study. Ther Apher Dial. 22(5):503-508, 2018.
13. Tsuji T, Ohishi K, Takeda A, Goto D, Sato T, Ohashi N, Fujigaki Y, Kato A, Yasuda H. The impact of serum uric acid reduction on renal function and blood pressure in chronic kidney disease patients with hyperuricemia. Clin Exp Nephrol. 22(6):1300-1308, 2018.
14. Yasuda H. Is immunosenesence good for kidney injury? Kidney Res Clin Pract. 38(1):1-2, 2019.
15. Ono M, Ohashi N, Namikawa A, Katahashi N, Ishigaki S, Tsuji N, Isobe S, Iwakura T, Sakao Y, Tsuji T, Kato A, Fujigaki Y, Shimizu A, Yasuda H. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome. Intern Med. 57(11):1617-1623, 2018.
16. Goto D, Ohashi N, Takeda A, Fujigaki Y, Shimizu A, Yasuda H, Ohishi K. Case of human immunodeficiency virus infection presenting as a tip variant of focal segmental glomerulosclerosis: A case report and review of the literature. World J Nephrol. 7: 90-95, 2018.
17. Kaneko M, Fukasawa H, Ishibuchi K, Niwa H, Yasuda H, Furuya R. L-carnitine Improved the Cardiac Function via the Effect on Myocardial Fatty Acid Metabolism in a Hemodialysis Patient. Intern Med. 2018 Dec 15;57(24):3593-3596
邦文総説など
1. 後藤大樹 安田日出夫 肝腎症候群 AKI急性腎障害治療の実際 日本医事新報社 東京 p90-95
1. Fujikura T, Yasuda H, Iwakura T, Tsuji T, Anders HJ. MDM2 inhibitorameliorates cisplatin-induced nephropathy via NFκΒ signal inhibition. Pharmacol Res Perspect. 2018 Dec 13;7(1):e00450
2. Matsuyama T, Ohashi N, Ishigaki S, Isobe S, Tsuji N, Fujikura T, Tsuji T, Kato A, Miyajima H, Yasuda H. The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function. Intern Med.;57(22):3241-3247, 2018
3. Ishigaki S, Ohashi N, Isobe S, Tsuji N, Iwakura T, Ono M, Sakao Y, Tsuji T, Kato A, Miyajima H, Yasuda H. Correction to: Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease. Clin Exp Nephrol. 23(2):289-290, 2019.
4. Ohashi N, Isobe S, Matsuyama T, Ishigaki S, Suzuki T, Tsuji T, Otsuka A, Kato A, Miyake H, Yasuda H. The Intrarenal Renin-angiotensin System Is Activated Immediately after Kidney Donation in Kidney Transplant Donors. Intern Med. 58(5):643-648, 2019.
5. Ohashi N, Isobe S, Matsuyama T, Ishigaki S, Tsuji N, Fujikura T, Tsuji T,Kato A, Yasuda H. Night-time activation of the intrarenal renin-angiotensin system due to nocturnal hypertension is associated with renal arteriosclerosis in normotensive IgA nephropathy patients. Hypertens Res. 41(5):334-341, 2018.
6. Sakao Y, Ohashi N, Sugimoto M, Ichikawa H, Sahara S, Tsuji T, Kato A, Fujigaki Y, Sugimoto K, Furuta T, Yasuda H. Gender differences in plasma ghrelin levels in hemodialysis patients. Ther Apher Dial 23:65-72, 2018.
7. Sahara S, Sugimoto M, Ichikawa H, Kagami T, Sakao Y, Ohashi N, Horio Y, Sugimoto K, Kato A, Furuta T, Yasuda H: Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial. Digestion 97: 163-169, 2018.
8. Ichikawa H, Sugimoto M, Sakao Y, Sahara S, Ohashi N, Sano K, Tadokoro S, Azekura H, Shimomura A, Yamashita F, Sugiyama D, Fukuta K, Furuta T, Kato A, Sugimoto K, Yasuda H. Eradication therapy for Helicobacter pylori infection improves nutrition status in Japanese hemodialysis patients: a pilot study. J Clin Biochem Nutr. 64(1):91-95, 2019.
9. Sakao Y,Ohashi N,Sugimoto M,Ichikawa H,Sahara S,Tsuji T,Kato A,Fujigaki Y,Sugimoto K,Furuta T,Yasuda H.Gender Differences in Plasma Ghrelin Levels in Hemodialysis Patients.Ther Apher Dial. 23(1):65-72, 2019.
10. Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T,Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K,Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, ShirasakiA, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K,Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R,Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y. Regionalvariations in immunosuppressive therapy in patients with primary nephroticsyndrome: the Japan nephrotic syndrome cohort study. Clin Exp Nephrol. 2018Dec;22(6):1266-1280.
11. Sugimoto M, Yasuda H, Andoh A. Nutrition status and Helicobacter pylori nfection in patients receiving hemodialysis. World J Gastroenterol. 24(15):1591-1600, 2018.
12. Niwa H, Fukasawa H, Ishibuchi K, Kaneko M, Yasuda H, Furuya R. Effects ofLowering Dialysate Calcium Concentration on Bone Metabolic Markers in Hemodialysis Patients With Suppressed Serum Parathyroid Hormone: A Preliminary Study. Ther Apher Dial. 22(5):503-508, 2018.
13. Tsuji T, Ohishi K, Takeda A, Goto D, Sato T, Ohashi N, Fujigaki Y, Kato A, Yasuda H. The impact of serum uric acid reduction on renal function and blood pressure in chronic kidney disease patients with hyperuricemia. Clin Exp Nephrol. 22(6):1300-1308, 2018.
14. Yasuda H. Is immunosenesence good for kidney injury? Kidney Res Clin Pract. 38(1):1-2, 2019.
15. Ono M, Ohashi N, Namikawa A, Katahashi N, Ishigaki S, Tsuji N, Isobe S, Iwakura T, Sakao Y, Tsuji T, Kato A, Fujigaki Y, Shimizu A, Yasuda H. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome. Intern Med. 57(11):1617-1623, 2018.
16. Goto D, Ohashi N, Takeda A, Fujigaki Y, Shimizu A, Yasuda H, Ohishi K. Case of human immunodeficiency virus infection presenting as a tip variant of focal segmental glomerulosclerosis: A case report and review of the literature. World J Nephrol. 7: 90-95, 2018.
17. Kaneko M, Fukasawa H, Ishibuchi K, Niwa H, Yasuda H, Furuya R. L-carnitine Improved the Cardiac Function via the Effect on Myocardial Fatty Acid Metabolism in a Hemodialysis Patient. Intern Med. 2018 Dec 15;57(24):3593-3596
邦文総説など
1. 後藤大樹 安田日出夫 肝腎症候群 AKI急性腎障害治療の実際 日本医事新報社 東京 p90-95